UK: +44 (0)1223 264428
USA: +1 (650) 798 5134
Innovative design and technology consultancy Cambridge Design Partnership has appointed Alan Cucknell as Front End Innovation Leader and Tom Lawrie-Fussey as Technology Business Development Lead, further strengthening the specialist innovation and digital capabilities within the team.
An experienced new product developer, Alan has spent over 14 years working in strategic design innovation and front-end research projects, primarily with blue chip companies. At Cambridge Design Partnership he will be responsible for identifying strategic opportunities for clients and working alongside the multi-disciplinary team to translate these into successful products.
Alan has worked for a number of world-class companies, including Procter & Gamble, Electrolux, Lego, Wonderbra, The North Face, and Anheuser Busch AB InBev.
Tom Lawrie-Fussey will head up the Technology Business Development team at Cambridge Design Partnership. His focus will be working with clients to develop ground-breaking new products to solve unmet needs and maximise their investment in connected devices by supporting their digital strategies and unlocking revenue potential.
With an engineering degree from Cambridge, Tom has worked as an engineering consultant for more than 10 years, including a role in the automotive industry with Bentley Motors and a large Cambridge engineering consultancy.
Commenting on the new hires, Mike Cane, Founder of Cambridge Design Partnership, said: “Building our skills and capabilities is at the heart of our strategy to offer our clients outstanding creativity and high quality innovation. Alan and Tom further strengthen our development teams, bringing decades of engineering and design expertise that will ensure we meet the needs of our increasing client base.”
To find out more about Alan Cucknell and Tom Lawrie-Fussey, read their meet the team blogs. To contact Alan or Tom, email email@example.com
Using smart packaging to support consumer trials
A novel approach to drug delivery to improve adherence and the patient experience